Overview

Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

A phase III trial of induction chemotherapy followed by definitive radiotherapy plus Cetuximab versus chemoradiation in unresectable, locally advanced, squamous cell carcinoma of the head and neck (HNC).

Phase:

Phase 3

Details

Lead Sponsor:

Gruppo Oncologico del Nord-Ovest

Treatments:

Cetuximab
Cisplatin
Docetaxel
Fluorouracil